The Food and Drug Administration yesterday released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration between FDA, the National Institute of Health’s National Cancer Institute, Centers for Disease Control and Prevention and Biomedical Advanced Research and Development Authority. Meanwhile, a new video from FDA explains for the public the different categories of COVID-19 tests, such as tests for those currently infected versus those with antibodies.

FDA June 3 also approved a new sedation injection for intubated and ventilated patients in intensive care settings and non-intubated patients prior to or during surgical and other procedures. The drug’s most common side effects are hypotension, bradycardia and dry mouth.

Related News Articles

Headline
The Mount Sinai Health System will partner with Emergent BioSolutions and ImmunoTek Bio Centers on the development and evaluation of a COVID-19 hyperimmune…
Headline
Gilead Sciences yesterday said it is starting phase one clinical study of inhaled remdesivir for potential outpatient treatment of COVID-19. In a statement,…
Headline
UR Medicine Thompson Health, a nonprofit health care system which provides care for 165,000 residents of Upstate New York’s greater Finger Lakes area and is…
Headline
The Department of Veterans Affairs July 8 will host a webinar featuring clinicians who will present a case-based educational session on performing cognitive…
Headline
The Food and Drug Administration Monday authorized the emergency use of the BD (Becton Dickinson) Veritor System for Rapid Detection of SARS-CoV-2. The test…
Headline
The Environmental Protection Agency yesterday approved two Lysol products following testing indicating that both safely and effectively kill the virus that…